Related Experiment Video
Updated: Nov 7, 2025

08:31
Porous Silicon Microparticles for Delivery of siRNA Therapeutics
Published on: January 15, 2015
11.2K
Cell-Penetrating Peptides Delivering siRNAs: An Overview
Luca Falato1, Maxime Gestin2, Ülo Langel2,3
1Department of Biochemistry and Biophysics, Arrhenius Laboratories for Natural Sciences, Stockholm University, Stockholm, Sweden. luca.falato@dbb.su.se.
Methods in Molecular Biology (Clifton, N.J.)
|April 30, 2021
Summary
Cell-Penetrating Peptides (CPPs) facilitate the cellular delivery of small interfering RNAs (siRNA) for gene silencing. Complex formation and CPP-decorated nanocomplexes are promising strategies for effective siRNA delivery, enhancing therapeutic potential.
Area of Science:
- Biotechnology
- Molecular Biology
- Drug Delivery Systems
Background:
- Cell-Penetrating Peptides (CPPs) enable intracellular delivery of therapeutic molecules.
- Small interfering RNAs (siRNAs) are potent gene silencers but face delivery challenges due to membrane impermeability and short half-life.
- RNA interference (RNAi) pathway is a key target for therapeutic intervention.
Purpose of the Study:
- To review and assess various strategies for delivering siRNA into cells using CPPs.
- To compare different CPP-siRNA loading methods developed over the past two decades.
- To identify the most promising CPP-based siRNA delivery approaches for future clinical applications.
Main Methods:
- Overview of literature on CPP-mediated siRNA delivery.
- Categorization of delivery strategies into covalent conjugation, complex formation, and CPP-decorated nanocomplexes.
- Analysis of the advantages and disadvantages of each loading strategy.
Main Results:
- Covalent conjugation, complex formation, and CPP-decorated nanocomplexes are key CPP-siRNA loading strategies.
- Complex formation and CPP-decorated nanocomplexes are emerging as versatile and user-friendly methods.
- Recent advancements focus on targeted delivery to improve efficacy and reduce side effects.
Conclusions:
- CPP-mediated siRNA delivery holds significant promise for therapeutic applications.
- Complex formation and nanocomplex strategies offer practical advantages for siRNA delivery.
- Targeted delivery approaches are crucial for optimizing CPP-siRNA therapeutics in clinical settings.
Related Concept Videos
siRNA - Small Interfering RNAs
17.5K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
17.5K
Experimental RNAi
6.7K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.7K
RNA Interference
27.0K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
27.0K
piRNA - Piwi-interacting RNAs
7.2K
PIWI-interacting RNAs, or piRNAs, are the most abundant short non-coding RNAs. More than 20,000 genes have been found in humans that code for piRNAs while only 2000 genes have been found for miRNAs. piRNAs can act at the transcriptional and post-transcriptional levels and have a vital role in silencing transposable elements present in germ cells. They are also involved in epigenetic silencing and activation. Previously, they were thought to function only in germ cells but new evidence suggests...
7.2K

